Notice to attend the annual general meeting in SciBase Holding AB (publ) lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
The number of shares and votes in Infant Bacterial Therapeutics AB has changed due to the recently completed rights issue . Through the rights issue, the number of shares in IBT increased with.
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. The Board of Directors of Infant Bacterial Therapeutics AB (publ) (“
In accordance with the study protocol, the independent Data Monitoring Committee has performed the final planned safety analysis of Infant Bacterial Therapeutics AB drug candidate IBP-9414. The. | June 21, 2023
“IBT announced earlier today that the Data Monitoring Committee (DMC) has performed the planned safety analysis of the study data of 1,403 babies. We have now also received results from the pre-planned futility analysis. It is therefore with great.